aheilbut + transparency   47

Drug Makers Share Data From Failed Trials - WSJ.com
A group of major pharmaceutical companies will share pooled data from failed clinical trials in an attempt to figure out what is going wrong in the studies and what can be done to improve drug development.
The data will be available to all the participating drug makers, as well as outside researchers with a valid scientific question, Dr. Cantillon said.
pharma  collaboration  transparency  fda 
june 2010 by aheilbut
NEJM -- Rosiglitazone and Cardiovascular Risk
The health of the public would benefit from additional revisions to the drug-safety legislation as it moves through the House of Representatives.
rosiglitizone  avandia  transparency  clinicaltrials 
may 2007 by aheilbut

Copy this bookmark:



description:


tags: